Diabetes drug study aims to stop heart failure before it starts
NCT ID NCT03744975
First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 18 times
Summary
This study looked at how a drug called LCZ696 (used for heart failure) affects the kidneys and heart in 72 people with type 2 diabetes, some with early signs of heart stiffness and some without. Participants received a salt solution to test their body's response. The goal was to understand if this drug can prevent progression to symptomatic heart failure. The study is complete, but results are not yet reported.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.